Food & Herbal Plant Extract Ingredient Manufacturer Malaysia.

Chamomile (Matricaria chamomilla): Apigenin, Mechanism & B2B Sourcing

Chamomile (Matricaria chamomilla, German chamomile) is one of the most-used calming botanicals. Its marker compound is the flavone apigenin; it works largely through the GABA-A benzodiazepine site; and it has placebo-controlled trial support in anxiety. This guide covers the active compound, the mechanism, the clinical evidence and how to source a chamomile ingredient for B2B formulation.

Molecular structures of the standardisation markers
Molecular structures of the named standardisation markers. Formulae computationally verified. Analytical identifiers only — no medicinal claims.
Body pharmacology as described in published studies
Absorption, metabolism, distribution, studied mechanisms and elimination — every value attributed to the published study named in that step, not to Bionutricia.

Active compound & standardisation

German chamomile is characterised by the flavone apigenin (and its glycoside apigenin-7-O-glucoside), together with an essential oil rich in α-bisabolol and chamazulene. A quality chamomile ingredient is standardised on apigenin by HPLC — the clinical extract used about 1.2% apigenin — which serves as the identity-and-consistency marker for each batch.

How chamomile works (mechanism)

Apigenin is a partial agonist at the benzodiazepine binding site of GABA-A receptors, the principal inhibitory neurotransmitter system in the brain — the accepted pharmacological basis for chamomile’s calming and sleep-supportive research. Apigenin also modulates monoamine (serotonin, dopamine, noradrenaline) signalling, while the oil’s bisabolol and chamazulene contribute anti-inflammatory and spasmolytic activity behind chamomile’s traditional digestive and skin uses. Mechanism is provided as scientific background on the botanical; it is not a claim that any finished product treats, cures or prevents a condition.

Clinical evidence

Study Design Result (attributed to the study)
Amsterdam et al. 2009, J Clin Psychopharmacol Placebo-controlled RCT, n=57, standardised extract 220-1,100 mg/day, 8 weeks Significant reduction in Hamilton Anxiety (HAM-A) scores vs placebo (p=0.047) in generalised anxiety
Mao et al. 2016 Long-term study, 1,500 mg/day chamomile extract Explored maintenance and relapse in the studied group

Trials use specific apigenin-standardised extracts; results describe those preparations, not any finished product. Sleep-specific trials have been mixed.

Sourcing chamomile as a B2B ingredient

Chamomile is not a current Bionutricia catalogue SKU. Bionutricia is a JAKIM Halal-certified botanical extract manufacturer (also FSSC 22000, US FDA-registered, GMP, HACCP, MeSTI) that develops standardised extracts for brand owners. A company wanting a halal, apigenin-standardised chamomile ingredient can enquire about custom development and OEM manufacturing.

Frequently asked questions

What is the active compound? The flavone apigenin (apigenin-7-glucoside), by HPLC; ~1.2% in the clinical extract.

How does it work? Partial agonism at the GABA-A benzodiazepine site; plus anti-inflammatory oil constituents.

What does the evidence show? Amsterdam 2009 (n=57): significant HAM-A reduction vs placebo in anxiety.

Does Bionutricia sell it? Not a catalogue SKU; custom halal OEM development can be enquired about.

Safety? Well tolerated; Asteraceae-allergy caution; high doses usually avoided in pregnancy; follow local claim rules.

Enquire about custom botanical extract development →

Bionutricia Manufacturing Sdn Bhd (201001031866 / 915789-W) © 2026. All Rights Reserved.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping